Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huanggang Huayang Pharmaceutical was a China-based manufacturer of pharmaceutical raw materials, nutraceutical ingredients, and intermediates, best known for its carnitine product line. Trade and supplier directories describe the company as founded in 2002 in Luotian County, Hubei, with manufacturing capabilities for L-carnitine series products, folic acid, guanine, and statin/cardiovascular intermediates. Multiple later sources indicate that the business was subsequently renamed or succeeded by Hubei Truevita Pharmaceutical Co., Ltd., founded in 2018 in Huanggang, and that Huanggang Huayang Pharmaceutical is the former company name. Based on available evidence, the Huayang entity appears to have been an operating healthcare-related manufacturer with commercial products rather than a drug-development biotech company with a disclosed clinical pipeline. Its business was oriented toward production, quality control, and supply of APIs, additives, and specialty ingredients for pharmaceutical, nutrition, feed, and related markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huanggang Huayang Pharmaceutical.